Digital surgery innovator Activ Surgical has announced that it has been named the newest member of Microsoft for Startups, a programme that helps B2B start-ups with successful scaling.
With the development, Activ Surgical will have exclusive access to Microsoft’s technologies such as Azure and an efficient path to selling alongside Microsoft and its global partner ecosystem.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Furthermore, Activ Surgical’s participation in the programme and collaboration with Microsoft will aid in increasing opportunities for hospitals and healthcare systems in the US and international markets to use its recently announced ActivEdge platform.
An artificial intelligence (AI) and machine learning (ML) hardware-agnostic platform, ActivEdge enables existing surgical systems to see in real-time what humans are not able to see, including blood flow.
The first product to be launched from ActivEdge, the company’s ActivSight offers real-time views of blood perfusion without requiring dye injection and enables fluorescing of indocyanine green (ICG) dye.
Furthermore, it operates dynamically and effortlessly with any installed visualisation system to deliver real-time intraoperative visual data and images not available at present to surgeons using existing technologies.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataActiv Surgical chief technology officer Tom Calef said: “Our participation in the programme comes at a critical time in our company’s history as we prepare for the commercialisation of our first product, ActivSight, later this year.
“And, given our ActivEdge platform is currently powered by Microsoft Azure, we will now have expanded access to resources, capabilities, and ecosystem partners that will ensure the success of the go-to-market rollout.”
The company noted that it has sought the Food and Drug Administration (FDA) clearance for ActivSight and is anticipated to be commercially available this year.
Microsoft for Startups Health & Life Sciences WW Lead Sally Frank said: “Activ Surgical’s mission to save lives and improve patient safety and outcomes by reducing surgical errors in the operating room is bold and represents the types of companies we want to align with as part of our start-up programme.”
